Press release
Recombinant Proteins Market Overview by recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2031 | Abcam PLC, Amgen Inc, Bio-Rad Laboratories Inc.
New York, Global Recombinant Proteins Market report from Global Insight Services is the single authoritative source of intelligence on Recombinant Proteins Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-customization/GIS21085
Recombinant proteins are proteins that are produced by cells that have been genetically engineered to express a specific gene. These proteins can be used for a variety of purposes, including research, therapeutics, and diagnostics. Recombinant proteins are often used in basic research to study the function of a particular gene or protein. They can also be used to create new therapeutic and diagnostic products.
Key Trends
The key trends in recombinant proteins technology are the development of new methods for producing and purifying recombinant proteins, the development of new methods for characterizing and analyzing recombinant proteins, and the increasing use of recombinant proteins in basic research and biotechnology.
One of the most important developments in recombinant protein technology has been the development of new methods for producing and purifying recombinant proteins.
Read more about Recombinant Proteins Market here: https://www.globalinsightservices.com/reports/recombinant-proteins-market/
Key Drivers
The key drivers of the recombinant proteins market are the increasing demand for biopharmaceuticals, the rising demand for monoclonal antibodies (mAbs), and the increasing investment in research and development activities by biopharmaceutical companies.
The increasing demand for biopharmaceuticals is driven by the growing prevalence of chronic diseases, such as cancer and diabetes, and the need for effective treatments for these conditions.
Market Segmentation
By Product
Structural Proteins
Membrane Proteins
By Application
Drug Discovery
Biotechnology Research
By End-Use
Pharmaceutical Companies
Biotechnology Companies
By Region
North America
US
Get A Customized Scope to Match Your Need Ask an Expert - https://www.globalinsightservices.com/request-customization/GIS21085
Key Players
Abcam PLC
Amgen Inc
Bio-Rad Laboratories Inc.
Eli Lilly and Company
Enzo Biochem Inc
Merck KGaA
Novo Nordisk AS
ProSpec-Tany TechnoGene Ltd
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS21085
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Proteins Market Overview by recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2031 | Abcam PLC, Amgen Inc, Bio-Rad Laboratories Inc. here
News-ID: 3148298 • Views: …
More Releases from Global Insight Services

Handmade Jewelry Market Expected to Grow from $203.8 Billion in 2024 to $594.3 B …
The Handmade Jewelry Market has emerged as a vibrant and fast-growing sector, driven by the rising consumer preference for artisanal, personalized, and ethically produced accessories. Handmade jewelry encompasses a wide array of products, including necklaces, bracelets, earrings, rings, and other unique adornments, often crafted using precious metals, gemstones, and innovative materials. Unlike mass-produced jewelry, handmade pieces resonate with consumers seeking individuality, sustainability, and artistic expression. The market benefits greatly from…

Gene Silencing Market Expected to Grow from $4.66 Billion in 2024 to $11.31 Bill …
The Gene Silencing Market is emerging as one of the most promising areas in biotechnology and medical research. By using advanced tools to suppress gene expression, scientists can better understand genetic functions and design treatments for diseases at their roots. Techniques such as RNA interference (RNAi), antisense oligonucleotides, and CRISPR-based approaches have broadened the scope of applications, from therapeutic innovations to agricultural advancements. This market not only reflects the cutting…

Risk Management Software Market Is Anticipated To Expand From $14.9 Billion In 2 …
Market Overview
The Risk Management Software Market is becoming an essential pillar for organizations across industries as they navigate an increasingly complex business environment. Companies face rising challenges ranging from regulatory compliance and cybersecurity threats to operational inefficiencies and supply chain disruptions. Risk management software provides a unified solution to identify, monitor, and mitigate these risks, enabling organizations to make informed decisions while safeguarding business continuity. These tools are not limited…

Rare Disease Treatment Market Expected to Grow from $213.5 Billion in 2024 to $5 …
The Rare Disease Treatment Market is emerging as one of the most dynamic sectors in the global healthcare landscape. This market focuses on the development, production, and distribution of therapies designed to address rare and complex medical conditions affecting a small percentage of the population. Rare diseases, often genetic in origin, pose significant treatment challenges, which has prompted biopharmaceutical companies to invest in innovative solutions such as orphan drugs, gene…
More Releases for Recombinant
Recombinant Peptide Market: A Comprehensive Overview
Recombinant Peptide Market was valued at around USD 5.5 billion in 2023 and is expected to reach approximately USD 14.6 billion by 2033, growing at a compound annual growth rate (CAGR) of about 10.2% over the period 2024-2033.
Recombinant Peptide Market Overview
The recombinant peptide market is experiencing rapid growth as advancements in peptide synthesis and recombinant DNA technologies lower production costs and enhance specificity. These peptides are increasingly integrated into therapeutic…
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
Recombinant Collagen Market Outlook and Investment Analysis
Top companies
Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies
Recombinant Collagen Market: Trends & Investment Analysis
Market Growth: The recombinant collagen…
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
Recombinant Collagen Market Outlook and Investment Analysis
Top companies
Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies
Recombinant Collagen Market: Trends & Investment Analysis
Market Growth: The recombinant collagen…
Global Recombinant Cell Culture Supplements Market Size - By Product Type(Recomb …
Recombinant Cell Culture Supplements Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Recombinant Cell Culture Supplements Market Scope: Unveiling Today's Trends
Recombinant Cell Culture Supplements are specialized products designed to enhance growth and productivity in cells used for research and bioproduction.
The market for these supplements is experiencing substantial growth, driven by the rising demand for biopharmaceuticals and advancements in biotechnology. Increasing investments in research and development activities also contribute to market…
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The next…